Literature DB >> 24795227

An algorithm developed using the Brighton Collaboration case definitions is more efficient for determining diagnostic certainty.

Deepa Joshi1, Emily Alsentzer2, Kathryn Edwards3, Allison Norton4, Sarah Elizabeth Williams5.   

Abstract

The Brighton Collaboration is a global research network focused on vaccine safety. The Collaboration has created case definitions to determine diagnostic certainty for several adverse events. Currently nested within multi-page publications, these definitions can be cumbersome for use. We report the results of a randomized trial in which the case definition for anaphylaxis was converted into a user-friendly algorithm and compared the algorithm with the standard case definition. The primary outcomes were efficiency and accuracy. Forty medical students determined the Brighton Level of diagnostic certainty of a sample case of anaphylaxis using either the algorithm or the original case definition. Most participants in both groups selected the correct Brighton Level. Participants using the algorithm required significantly less time to review the case and determine the level of diagnostic certainty [mean difference=107 s (95% CI: 13-200; p=0.026)], supporting that the algorithm was more efficient without impacting accuracy.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adverse events following immunization; Brighton Collaboration; Vaccine safety monitoring

Mesh:

Year:  2014        PMID: 24795227     DOI: 10.1016/j.vaccine.2014.04.070

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  3 in total

1.  Innovative Digital Tools and Surveillance Systems for the Timely Detection of Adverse Events at the Point of Care: A Proof-of-Concept Study.

Authors:  Christian Hoppe; Patrick Obermeier; Susann Muehlhans; Maren Alchikh; Lea Seeber; Franziska Tief; Katharina Karsch; Xi Chen; Sindy Boettcher; Sabine Diedrich; Tim Conrad; Bron Kisler; Barbara Rath
Journal:  Drug Saf       Date:  2016-10       Impact factor: 5.606

2.  Immediate Reactions After the First Dose of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Messenger RNA Vaccines Do Not Preclude Second-Dose Administration.

Authors:  Kristine Vanijcharoenkarn; Frances Eun-Hyung Lee; Lindsay Martin; Jennifer Shih; Mary Elizabeth Sexton; Merin Elizabeth Kuruvilla
Journal:  Clin Infect Dis       Date:  2021-12-06       Impact factor: 9.079

3.  A descriptive study of ciguatera fish poisoning in Cook Islands dogs and cats: Exposure history, clinical signs, and formulation of a case definition.

Authors:  Michelle J Gray; M Carolyn Gates
Journal:  Vet World       Date:  2020-02-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.